프로그램
Translating Discovery into Cancer Cure
• Scientific Program (As of October 26, 2017)
| Plenary Lecture 1 | 11:00-11:50, Crystal Ballroom |
|---|---|
| The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival | |
| Chair: Eun Kyung Choi (University of Ulsan College of Medicine) | |
| Peter Sicinski, M.D., Ph.D. (Professor of Genetics, Harvard Medical School and Dana-Farber Cancer Institute, USA) | |
| Plenary Lecture 2 | 13:10-14:00, Crystal Ballroom |
| Functional genomics approaches to identify vulnerabilities in cancer cells | |
| Chair: Young-Joon Surh (Seoul National University College of Pharmacy) | |
| Mathew Garnett, Ph.D. (Group Leader of Translational Cancer Genomics Laboratory, Wellcome Trust Sanger Institute, UK) | |
| Symposium 1 | 09:00-10:40, Crystal Ballroom A |
| Cancer epigenetics | |
| 좌장: 엄수종 (세종대학교), 이연수 (국립암센터) | |
| 1) Epigenetic regulation of gene expression dynamics | 김태수 (이화여대 자연과학대학) |
| 2) Extracelluar vesicle microRNAs as non-invasive biomarkers in colorectal cancer | 노태영 (POSTECH) |
| 3) Variability in chromatin architecture and associated DNA repair at genomic positions containing somatic mutations | 김선영 (한국생명공학연구원) |
| Symposium 2 | 09:00-10:40, Crystal Ballroom B |
| Rare tumor in the era of precision medicine | |
| 좌장: 박병규 (국립암센터), 라선영 (연세의대) | |
| 1) Updates in sarcomas | 이준아 (한국원자력의학원) |
| 2) Molecular profiling of rare tumor | 최윤라 (성균관의대) |
| 3) Computer-assistance for precision surgery | 조환성 (분당서울대학교병원) |
| 4) Personalized therapy for sarcoma | 안진희 (울산의대) |
| Symposium 3 | 09:00-10:40, Emerald room |
| Immunotherapy beyond PD1/PDL1 | |
| 좌장: 조재용 (연세의대), 하상준 (연세대학교) | |
| 1) Immune checkpoint receptors targeting to enhance Cetuximab therapy | 지현배 (Ambrx, USA) |
| 2) Natural killer cell therapy for refractory leukemia | 최인표 (한국생명공학연구원) |
| 3) Targeting Treg in cancer immunotherapy | 김용성 (아주대 공과대학) |
| 4) The promise and challenges of current immune checkpoint blockade approaches in cancer immunotherapy | 최인학 (인제의대) |
| Symposium 4 | 14:25-16:05, Crystal Ballroom A |
| Single cell genomics | |
| 좌장: 박웅양 (삼성서울병원), 공구 (한양의대) | |
| 1) Single cell transcriptome analysis unveils tumor microenvironment | 이혜옥 (삼성서울병원) |
| 2) Accounting for technical noise in single-cell RNA-seq | 김종경 (DGIST) |
| 3) Single cell genomics for breast cancer to overcome tumor heterogeneity | 한원식 (서울의대) |
| Symposium 5 | 14:25-16:05, Crystal Ballroom B |
| Farewell to 2Gy dogma | |
| 좌장: 박희철 (성균관의대), 김태현 (국립암센터) | |
| 1) Extreme diversity of radiation dose prescription in lung cancer | 조재호 (연세의대) |
| 2) Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery | 신경환 (서울의대) |
| 3) Hypofractionated radiotherapy for hepatic malignancies | 윤상민 (울산의대) |
| 4) Hypofractionated preoperative radiotherapy in rectal cancer | 이종훈 (가톨릭의대) |
| Symposium 6 | 14:25-16:05, Emerald room |
| DNA repair pathway as therapeutic target in cancers | |
| 좌장: 안중배 (연세의대), 이석형 (가톨릭의대) | |
| 1) A molecular portrait of microsatellite instability across multiple cancers | 김태민 (가톨릭의대) |
| 2) TonEBP promotes recurrence of hepatocellular carcinoma: role of nucleotide exchange repair | 권혁무 (UNIST) |
| 3) Clinical implication of deficiency in DNA repair pathway | 김정은 (울산의대) |
| Symposium 7 | 16:20-18:00, Crystal Ballroom A |
| AI in Oncology | |
| 좌장: 이은숙 (국립암센터), 이대호 (울산의대) | |
| 1) Artificial intelligence and precision medicine | 안성민 (가천의대) |
| 2) AI platform technology and use cases | 이강윤 (가천대 IT대학) |
| 3) Artificial intelligence in medical imaging | 서준범 (울산의대) |
| Symposium 8 | 16:20-18:00, Crystal Ballroom B |
| Genome editing | |
| 좌장: 이춘택 (분당서울대학교병원), 정연준 (가톨릭의대) | |
| 1) High performance resolution of cancer microsatellite instability and related haplotypes with in vitro CRISPR-Cas9 segmentation | Hanlee P. Ji (Stanford University School of Medicine) |
| 2) Mutant KRAS targeting using CRISPR-Cas9 | 김형범 (연세의대) |
| 3) Genome editing into safe harbor site of human chromosome for inducible gene expression | 조제열 (서울대 수의대) |
| 4) CRISPR-Cas9 in lung cancer research | 이춘택 (분당서울대학교병원) |
| Symposium 9 * 대한산부인과학회 공동심포지엄 | 16:20-18:00, Emerald room |
| Cancer and fertility preservation | |
| 좌장: 김승철 (이화의대), 김훈 (서울의대) | |
| 1) Fertility preservation for people with cancer | 김미란 (아주의대) |
| 2) Importance of early referral and referral system | 김자연 (차의대) |
| 3) Fertility preservation in oncology patients: oncologist perspectives | 박경화 (고려의대) |
| 4) Cancer treatment and future fertility: surgeons' perspective | 김희승 (서울의대) |
| Satellite Symposium 1 (by AstraZeneca) | 11:50-13:00, Crystal Ballroom A |
| 좌장: 강진형 (가톨릭의대) | |
| Osimertinib, a third-generation EGFR inhibitor: from discovery to the clinic | 김태민 (서울의대) |
| Satellite Symposium 2 (by Bayer) | 11:50-13:00, Crystal Ballroom B |
| 좌장: 김열홍 (고려의대) | |
| Treating advanced hepatocellular carcinoma: where are we today? | 류백렬 (울산의대) |
보완대체 요법에 대한 의료인과 환자의 인식조사 결과 |
14:00-14:15, Crystal Ballroom |
| 좌장: 라선영 (연세의대) | |
| 이상철 (순천향의대) | |